Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis - Scorecard - MDSpire

Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

  • By

  • Thiago Henrique Fernandes de Carvalho

  • Fabyan Beltrão Esberard

  • Maryana Cavalcanti Holanda

  • Matheus Venâncio de Paiva

  • Daniele Carvalhal de Almeida Beltrão

  • Giulia Carvalhal

  • José Felipe Lacerda Fernandes

  • Carlos Alexandre Antunes de Brito

  • February 13, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationHospitalized COVID-19 patients in northeastern Brazil
Care Setting

Key Highlights

  • Add specific percentages for GI symptoms and liver enzyme levels.

Guideline-Based Recommendations

Diagnosis

    Management

    • Monitor specific liver enzyme levels (e.g., AST, ALT) in hospitalized patients.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Focus on monitoring specific GI symptoms (e.g., diarrhea, nausea) and liver function tests during hospitalization.

        Clinical Best Practices

        • Implement regular monitoring of liver enzymes (e.g., every 48 hours) in hospitalized patients.

        References

        Original Source(s)

        Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

        • by Thiago Henrique Fernandes de Carvalho, Fabyan Beltrão Esberard, Maryana Cavalcanti Holanda, Matheus Venâncio de Paiva, Daniele Carvalhal de Almeida Beltrão, Giulia Carvalhal, José Felipe Lacerda Fernandes, Carlos Alexandre Antunes de Brito

        • February 13, 2026

        Related Content

        Integrating rapid response systems and patient centered goals of care discussions

        Antibiotics May Not Help Mild COVID

        A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

        Editorial: Lipid influence on lung immune-structural cell crosstalk: implications for respiratory health